Xeris Pharmaceuticals Announces Appointment of Paul R. Edick as President and CEO
09. Januar 2017 07:00 ET
|
Xeris Pharmaceuticals, Inc.
Austin, Texas, Jan. 09, 2017 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc., a specialty biopharmaceutical company focused on the development and commercialization of novel formulations of...
Xeris Pharmaceuticals, Inc. to Present G-Pen Human Factors Study Results at 2016 ATTD Meeting
04. Februar 2016 10:22 ET
|
Xeris Pharmaceuticals, Inc.
Austin, TX, Feb. 04, 2016 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (“Xeris”) will present data from a human factors study with its G-PenTM glucagon auto-injector during the 9th International...